99 related articles for article (PubMed ID: 3084115)
1. Enhancement of collagen-degrading enzymes in the dermis after one topical application of tumor-promoting phorbol esters.
Marian B
Carcinogenesis; 1986 May; 7(5):723-6. PubMed ID: 3084115
[TBL] [Abstract][Full Text] [Related]
2. Chronic 12-O-tetradecanoylphorbol-13-acetate treatment prevents restoration of collagen loss associated with its inflammatory effect on mouse skin.
Marian B
Cancer Lett; 1987 Mar; 34(3):273-82. PubMed ID: 3103908
[TBL] [Abstract][Full Text] [Related]
3. Tumor-promoting phorbol esters cause a stable reduction of dermal collagen in mouse skin.
Marian B
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1035-9. PubMed ID: 3117560
[TBL] [Abstract][Full Text] [Related]
4. Skin tumor promotion is associated with increased type V collagen content in the dermis.
Marian B; Danner MW
Carcinogenesis; 1987 Jan; 8(1):151-4. PubMed ID: 3100083
[TBL] [Abstract][Full Text] [Related]
5. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters.
Kumar S; Holmgren A
Carcinogenesis; 1999 Sep; 20(9):1761-7. PubMed ID: 10469622
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of neutral metalloproteinase in the dermis after one topical application of tumor-promoting phorbol ester.
Jendryczko A; Drózdz M; Skop B
Neoplasma; 1987; 34(6):659-63. PubMed ID: 3481042
[TBL] [Abstract][Full Text] [Related]
7. Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice.
Ushmorov AG; Fürstenberger G; Faissner A; Marks F
Carcinogenesis; 1994 Dec; 15(12):2739-45. PubMed ID: 7528111
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandins, cyclic nucleotides and the effect of phorbol ester tumor promoters on mouse skin in vivo.
Marks F
Carcinogenesis; 1983 Nov; 4(11):1465-70. PubMed ID: 6315256
[TBL] [Abstract][Full Text] [Related]
9. Multistage tumor promotion in skin.
Marks F; Fürstenberger G
Princess Takamatsu Symp; 1983; 14():273-87. PubMed ID: 6440893
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis.
Petrusevska RT; Fürstenberger G; Marks F; Fusenig NE
Carcinogenesis; 1988 Jul; 9(7):1207-15. PubMed ID: 3383339
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo.
Rose-John S; Fürstenberger G; Krieg P; Besemfelder E; Rincke G; Marks F
Carcinogenesis; 1988 May; 9(5):831-5. PubMed ID: 3365842
[TBL] [Abstract][Full Text] [Related]
12. Dermal collagen metabolism during tumor promotion with 12-O-tetradecanoylphorbol-13-acetate in mouse skin.
Marian B; Mazzucco K
Carcinogenesis; 1985 Apr; 6(4):501-4. PubMed ID: 3986956
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation.
Yamasaki H; Aguelon-Pegouries AM; Enomoto T; Martel N; Furstenberger G; Marks F
Carcinogenesis; 1985 Aug; 6(8):1173-9. PubMed ID: 3860306
[TBL] [Abstract][Full Text] [Related]
14. Effect of phorbol ester application and other mitogenic treatments on 3',5'-cyclic-nucleotide phosphodiesterase activity in mouse epidermis in vivo.
Marks F; Fürstenberger G
Hoppe Seylers Z Physiol Chem; 1980 Nov; 361(11):1641-50. PubMed ID: 6256278
[TBL] [Abstract][Full Text] [Related]
15. A novel protein (p10) induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and other hyperplasiogenic tumor-promoting and non-promoting agents in murine epidermis.
Schlatterer K; Krauter G; Schlatterer B; Hecker E; Chandra P
Anticancer Res; 1999; 19(1A):397-402. PubMed ID: 10226573
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics of tumour promoters of mouse skin. II. Metabolism of the tumour promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin and biological activities of metabolites.
Roeser H; Doege T; Hecker E
Carcinogenesis; 1991 Sep; 12(9):1563-70. PubMed ID: 1893516
[TBL] [Abstract][Full Text] [Related]
17. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.
Saleem M; Afaq F; Adhami VM; Mukhtar H
Oncogene; 2004 Jul; 23(30):5203-14. PubMed ID: 15122342
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
19. Modulation of oxidant formation in mouse skin in vivo by tumor-promoting phorbol esters.
Marnett LJ; Ji C
Cancer Res; 1994 Apr; 54(7 Suppl):1886s-1889s. PubMed ID: 8137305
[TBL] [Abstract][Full Text] [Related]
20. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Ertürk E; Bryan GT
Cancer Res; 1983 Dec; 43(12 Pt 1):5964-71. PubMed ID: 6315223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
